Back to STOK
Candriam S.C.A. STOK Position History
Stoke Therapeutics, Inc. • Healthcare
Quarters held
5
Latest value
$12.3M
Q3 2026
Peak value
$16.3M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $14.2M |
| Q4 2025 | $14.2M |
| Q1 2026 | $16.3M |
| Q2 2026 | $15.7M |
| Q3 2026 | $12.3M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $12.3M | 471.0K | — | — |
| Q2 2026 | $15.7M | 480.1K | — | — |
| Q1 2026 | $16.3M | 502.0K | — | — |
| Q4 2025 | $14.2M | 446.7K | — | — |
| Q4 2025 | $14.2M | 446.7K | — | — |
Other funds holding STOK
$110.4M
$109.6M
$107.8M
$93.3M
$93.3M
$79.8M
$74.1M